These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2209258)

  • 1. Behavioural pharmacology of nicotine: implications for multiple brain nicotinic receptors.
    Stolerman IP
    Ciba Found Symp; 1990; 152():3-16; discussion 16-22. PubMed ID: 2209258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist.
    Garcha HS; Thomas P; Spivak CE; Wonnacott S; Stolerman IP
    Psychopharmacology (Berl); 1993; 110(3):347-54. PubMed ID: 7831430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural effects of the nicotinic agonists N-(3-pyridylmethyl)pyrrolidine and isoarecolone in rats.
    Reavill C; Waters JA; Stolerman IP; Garcha HS
    Psychopharmacology (Berl); 1990; 102(4):521-8. PubMed ID: 2096409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural and biochemical adaptations to nicotine in rats: influence of MK801, an NMDA receptor antagonist.
    Shoaib M; Schindler CW; Goldberg SR; Pauly JR
    Psychopharmacology (Berl); 1997 Nov; 134(2):121-30. PubMed ID: 9399375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
    Smith JW; Mogg A; Tafi E; Peacey E; Pullar IA; Szekeres P; Tricklebank M
    Psychopharmacology (Berl); 2007 Feb; 190(2):157-70. PubMed ID: 17115136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine.
    el-Bizri H; Clarke PB
    Br J Pharmacol; 1994 Nov; 113(3):917-25. PubMed ID: 7858886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus properties of the nicotinic agonist cytisine.
    Chandler CJ; Stolerman IP
    Psychopharmacology (Berl); 1997 Feb; 129(3):257-64. PubMed ID: 9084064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine induces disinhibitory behavior in the rat after subchronic peripheral nicotinic acetylcholine receptor blockade.
    Ericson M; Olausson P; Engel JA; Söderpalm B
    Eur J Pharmacol; 2000 May; 397(1):103-11. PubMed ID: 10844104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.
    Grottick AJ; Trube G; Corrigall WA; Huwyler J; Malherbe P; Wyler R; Higgins GA
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1112-9. PubMed ID: 10945867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the receptor mediating the nicotine discriminative stimulus.
    Romano C; Goldstein A; Jewell NP
    Psychopharmacology (Berl); 1981; 74(4):310-5. PubMed ID: 6794072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural effects of anatoxin, a potent nicotinic agonist, in rats.
    Stolerman IP; Albuquerque EX; Garcha HS
    Neuropharmacology; 1992 Mar; 31(3):311-4. PubMed ID: 1630597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice.
    Pauly JR; Grün EU; Collins AC
    Psychopharmacology (Berl); 1990; 101(3):310-6. PubMed ID: 2362951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of nicotinic receptor function after chronic nicotine infusion.
    Marks MJ; Grady SR; Collins AC
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1268-76. PubMed ID: 8371136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats.
    Reavill C; Spivak CE; Stolerman IP; Waters JA
    Neuropharmacology; 1987 Jul; 26(7A):789-92. PubMed ID: 3627386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
    Khan IM; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 1994 Jul; 270(1):150-8. PubMed ID: 8035311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.
    Reavill C; Walther B; Stolerman IP; Testa B
    Neuropharmacology; 1990 Jul; 29(7):619-24. PubMed ID: 2385332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment.
    Pietilä K; Lähde T; Attila M; Ahtee L; Nordberg A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):176-82. PubMed ID: 9521491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognising nicotine: the neurobiological basis of nicotine discrimination.
    Smith JW; Stolerman IP
    Handb Exp Pharmacol; 2009; (192):295-333. PubMed ID: 19184654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.